BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7069267)

  • 41. Erythropoietic factors in plasma from neonatal mice. In vivo studies by the exhypoxic polycythaemic mice assay for erythropoietin.
    Sanengen T; Myhre K; Halvorsen S
    Acta Physiol Scand; 1987 Mar; 129(3):381-6. PubMed ID: 3577820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
    Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A specific in vitro bioassay for measuring erythropoietin levels in human serum and plasma.
    Wognum AW; Lam V; Goudsmit R; Krystal G
    Blood; 1990 Oct; 76(7):1323-9. PubMed ID: 2207309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Erythropoietin activity and erythropoietin inhibitor in plasma concentrates of patients with polycythemia vera].
    Essers U; Haddy T; Brunner E
    Verh Dtsch Ges Inn Med; 1973; 79():444-8. PubMed ID: 4790256
    [No Abstract]   [Full Text] [Related]  

  • 46. An enzyme-linked immunosorbent assay for erythropoietin using monoclonal antibodies, tetrameric immune complexes, and substrate amplification.
    Wognum AW; Lansdorp PM; Eaves AC; Krystal G
    Blood; 1989 Aug; 74(2):622-8. PubMed ID: 2473803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of erythroblast formation in suspension cultures of murine marrow by a factor in normal mouse serum, and its relationship to erythropoietin.
    Udupa KB; Reissmann KR
    Exp Hematol; 1980 Oct; 8(9):1106-13. PubMed ID: 7227467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low serum erythropoietin--a strong diagnostic criterion of primary polycythaemia even at normal haemoglobin levels.
    Messinezy M; Westwood NB; Woodcock SP; Strong RM; Pearson TC
    Clin Lab Haematol; 1995 Sep; 17(3):217-20. PubMed ID: 8719893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical validation of an RIA for natural and recombinant erythropoietin in serum and plasma.
    Goldberg MA; Schneider TJ; Khan S; Petersen JR
    Clin Biochem; 1993 Jun; 26(3):183-9. PubMed ID: 8330387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the mouse spleen cell assay and a radioimmunoassay for the measurement of serum erythropoietin.
    Lappin TR; Elder GE; Taylor T; McMullin MF; Bridges JM
    Br J Haematol; 1988 Sep; 70(1):117-20. PubMed ID: 3179219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythropoietin assay by hemagglutination-inhibition.
    Jordan TA; Potter TP; Essary BH
    Am J Med Technol; 1975 Apr; 41(4):146-53. PubMed ID: 1130426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inappropriate erythropoietin secretion in polycythemia vera.
    Chikkappa G; Burlington H; Chanana AD; Chandra P; Cronkite EP; Reincke U; Zanjani E
    Am J Hematol; 1977; 3():165-70. PubMed ID: 602935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Behavior and significance of plasmatic erythropoietin in primary and secondary polycythemias].
    Gambaro GC; Fresco G; Aranzulla G; Folco U
    Arch Maragliano Patol Clin; 1970; 26(3):153-80. PubMed ID: 5538114
    [No Abstract]   [Full Text] [Related]  

  • 55. [Erythropoietin determination in clinical medicine].
    Urabe A
    Rinsho Byori; 1993 Apr; 41(4):361-5. PubMed ID: 8350498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radioimmunologic determination of growth factors. II. Comparative development of methods for the determination of hematopoietic growth factors].
    Borota R; Popov J; Krajnović J
    Med Pregl; 1990; 43(7-8):317-22. PubMed ID: 2098644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Should whole-body red cell mass be measured or calculated?
    Balga I; Solenthaler M; Furlan M
    Blood Cells Mol Dis; 2000 Feb; 26(1):25-31; discussion 32-6. PubMed ID: 10772873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Behavior and significance of plasma erythropoietin in primary and secondary polycythemias].
    Gambaro GC; Fresco G; Aranzulla G; Folco U
    Haematologica; 1969; 54(11):731-47. PubMed ID: 4993247
    [No Abstract]   [Full Text] [Related]  

  • 59. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical usefulness of measurement of erythropoietin in blood].
    Yoshida Y; Hara H; Takahashi Y; Yamaguchi N; Kawagoe H; Shibata H; Ohno Y; Teshima H
    Rinsho Ketsueki; 1993 Aug; 34(8):895-903. PubMed ID: 8411644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.